Section Arrow
Quote
ALKS.NASDAQ
- Alkermes plc
Quotes are at least 15-min delayed:2026/03/28 19:09 EDT
Regular Hours
Last
 29.39
-0.53 (-1.77%)
Day High 
30.05 
Prev. Close
29.92 
1-M High
30.49 
Volume 
2.07M 
Bid
27
Ask
30
Day Low
29.2 
Open
29.9 
1-M Low
27 
Market Cap 
4.94B 
Currency 美元 
P/E 20.92 
%Yield -- 
10-SMA 28.26 
20-SMA 28.5 
50-SMA 31.3 
52-W High 36.3164 
52-W Low 25.165 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.43/-0.09
Enterprise Value
5.00B
Balance Sheet
Book Value Per Share
10.92
Cash Flow
Cash Flow Yield
0.10
Income Statement
Total Revenue
1.48B
Operating Revenue Per Share
9.63
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health19.38-1.48-7.09%40.92PE
HLNHaleon plc9.8+0.05+0.51%19.79PE
TEVATeva Pharmaceutical Industries Limited28.74-1.04-3.49%24.64PE
ELANElanco Animal Health23.13-1.45-5.90%355.43PE
VTRSViatris13.05-0.32-2.39%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.